Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
2 competitors in Metastatic Castration-resistant Prostate Cancer
View Full LandscapeTarget Indication
Metastatic Castration-resistant Prostate Cancer
Clinical Trial
NCT06520345Last updated: 1/31/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clear Cell Renal Cell Carcinoma
Prostate Cancer